Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 94

1.

Clinical phenotypes and outcomes of heritable and sporadic pulmonary veno-occlusive disease: a population-based study.

Montani D, Girerd B, Jaïs X, Levy M, Amar D, Savale L, Dorfmüller P, Seferian A, Lau EM, Eyries M, Le Pavec J, Parent F, Bonnet D, Soubrier F, Fadel E, Sitbon O, Simonneau G, Humbert M.

Lancet Respir Med. 2017 Feb;5(2):125-134. doi: 10.1016/S2213-2600(16)30438-6. Epub 2017 Jan 11.

PMID:
28087362
2.

Long-term outcome in liver transplantation candidates with portopulmonary hypertension.

Savale L, Sattler C, Coilly A, Conti F, Renard S, Francoz C, Bouvaist H, Feray C, Borentain P, Jaïs X, Montani D, Parent F, O'Connell C, Hervé P, Humbert M, Simonneau G, Samuel D, Calmus Y, Duvoux C, Durand F, Duclos-Vallée JC, Sitbon O.

Hepatology. 2016 Dec 20. doi: 10.1002/hep.28990. [Epub ahead of print]

PMID:
27997987
3.

BMPR2 mutation status influences bronchial vascular changes in pulmonary arterial hypertension.

Ghigna MR, Guignabert C, Montani D, Girerd B, Jaïs X, Savale L, Hervé P, Thomas de Montpréville V, Mercier O, Sitbon O, Soubrier F, Fadel E, Simonneau G, Humbert M, Dorfmüller P.

Eur Respir J. 2016 Dec;48(6):1668-1681. doi: 10.1183/13993003.00464-2016. Epub 2016 Nov 3.

PMID:
27811071
4.

Deterioration of pulmonary hypertension and pleural effusion with bosutinib following dasatinib lung toxicity.

Riou M, Seferian A, Savale L, Chaumais MC, Guignabert C, Canuet M, Magro P, Rea D, Sitbon O, Jaïs X, Humbert M, Montani D.

Eur Respir J. 2016 Nov;48(5):1517-1519. doi: 10.1183/13993003.01410-2016. Epub 2016 Oct 6. No abstract available.

PMID:
27799395
5.

A Clinical and Echocardiographic Score to Identify Pulmonary Hypertension Due to HFpEF.

Berthelot E, Montani D, Algalarrondo V, Dreyfuss C, Rifai R, Benmalek A, Jais X, Bouchachi A, Savale L, Simonneau G, Chemla D, Humbert M, Sitbon O, Assayag P.

J Card Fail. 2017 Jan;23(1):29-35. doi: 10.1016/j.cardfail.2016.10.002. Epub 2016 Oct 11.

PMID:
27742455
6.

Direct-Acting Antiviral Medications for Hepatitis C Virus Infection and Pulmonary Arterial Hypertension.

Savale L, Chaumais MC, Montani D, Jaïs X, Hezode C, Antonini TM, Coilly A, Duclos-Vallée JC, Samuel D, Simonneau G, Humbert M, Sitbon O.

Chest. 2016 Jul;150(1):256-8. doi: 10.1016/j.chest.2016.04.031. No abstract available.

PMID:
27396788
7.

Interferon-induced pulmonary hypertension: an update.

Savale L, Chaumais MC, O'Connell C, Humbert M, Sitbon O.

Curr Opin Pulm Med. 2016 Sep;22(5):415-20. doi: 10.1097/MCP.0000000000000307.

PMID:
27387101
8.

De-novo donor-specific anti-HLA antibodies 30 days after lung transplantation are associated with a worse outcome.

Le Pavec J, Suberbielle C, Lamrani L, Feuillet S, Savale L, Dorfmüller P, Stephan F, Mussot S, Mercier O, Fadel E.

J Heart Lung Transplant. 2016 Sep;35(9):1067-77. doi: 10.1016/j.healun.2016.05.020. Epub 2016 May 31.

PMID:
27373824
9.

Response to Letter Regarding Article, "Mitomycin-Induced Pulmonary Veno-Occlusive Disease: Evidence From Human Disease and Animal Model".

Perros F, Günther S, Ranchoux B, Godinas L, Antigny F, Chaumais MC, Dorfmüller P, Hautefort A, Raymond N, Savale L, Jaïs X, Girerd B, Cottin V, Sitbon O, Simonneau G, Humbert M, Montani D.

Circulation. 2016 Apr 5;133(14):e592-3. doi: 10.1161/CIRCULATIONAHA.116.020946. No abstract available. Erratum in: Circulation. 2016 May 10;133(19):e657-8.

PMID:
27045136
10.

Diagnostic concordance of different criteria for exercise pulmonary hypertension in subjects with normal resting pulmonary artery pressure.

Godinas L, Lau EM, Chemla D, Lador F, Savale L, Montani D, Jaïs X, Sitbon O, Simonneau G, Humbert M, Hervé P.

Eur Respir J. 2016 Jul;48(1):254-7. doi: 10.1183/13993003.01678-2015. Epub 2016 Mar 30. No abstract available.

PMID:
27030680
11.

Pulmonary veno-occlusive disease.

Montani D, Lau EM, Dorfmüller P, Girerd B, Jaïs X, Savale L, Perros F, Nossent E, Garcia G, Parent F, Fadel E, Soubrier F, Sitbon O, Simonneau G, Humbert M.

Eur Respir J. 2016 May;47(5):1518-34. doi: 10.1183/13993003.00026-2016. Epub 2016 Mar 23. Review.

PMID:
27009171
12.

Initial dual oral combination therapy in pulmonary arterial hypertension.

Sitbon O, Sattler C, Bertoletti L, Savale L, Cottin V, Jaïs X, De Groote P, Chaouat A, Chabannes C, Bergot E, Bouvaist H, Dauphin C, Bourdin A, Bauer F, Montani D, Humbert M, Simonneau G.

Eur Respir J. 2016 Jun;47(6):1727-36. doi: 10.1183/13993003.02043-2015. Epub 2016 Mar 17.

PMID:
26989105
13.

Lung capillary blood volume and membrane diffusion in precapillary pulmonary hypertension.

Godinas L, Amar D, Montani D, Lau EM, Jaïs X, Savale L, Jevnikar M, Sitbon O, Simonneau G, Humbert M, Laveneziana P, Garcia G.

J Heart Lung Transplant. 2016 May;35(5):647-56. doi: 10.1016/j.healun.2015.12.022. Epub 2016 Jan 6.

PMID:
26987595
14.

Resting pulmonary artery pressure of 21-24 mmHg predicts abnormal exercise haemodynamics.

Lau EM, Godinas L, Sitbon O, Montani D, Savale L, Jaïs X, Lador F, Gunther S, Celermajer DS, Simonneau G, Humbert M, Chemla D, Herve P.

Eur Respir J. 2016 May;47(5):1436-44. doi: 10.1183/13993003.01684-2015. Epub 2016 Mar 10.

PMID:
26965292
15.

A rare case of sarcoidosis-associated pulmonary hypertension in a patient exposed to silica.

Bourlier D, O'Connell C, Montani D, Savale L, Seferian A, Parent F, Humbert M, Simonneau G, Sitbon O, Jaïs X.

Eur Respir Rev. 2016 Mar;25(139):93-6. doi: 10.1183/16000617.0073-2015. No abstract available.

16.

Is there hope of improving the prognosis of pulmonary tumour thrombotic microangiopathy?

Merad M, Savale L, Antoun S, Vincent F; GrrrOH: Groupe de Recherche en Réanimation Respiratoire en Onco-Hématologie (Group for Research in Respiratory Intensive Care Onco-Hematology)..

Eur Respir J. 2016 Feb;47(2):688-90. doi: 10.1183/13993003.01276-2015. No abstract available.

PMID:
26828060
17.

Life-threatening Hughes-Stovin syndrome: The Yin and Yang of anticoagulation therapy.

Villié P, Noël N, Ackermann F, Rivoisy C, Le Pavec J, Savale L, Goujard C, Rocher L, Lambotte O.

Joint Bone Spine. 2016 Jul;83(4):459-60. doi: 10.1016/j.jbspin.2015.05.006. Epub 2015 Nov 19. No abstract available.

PMID:
26777106
18.

Comparative Safety and Tolerability of Prostacyclins in Pulmonary Hypertension.

O'Connell C, Amar D, Boucly A, Savale L, Jaïs X, Chaumais MC, Montani D, Humbert M, Simonneau G, Sitbon O.

Drug Saf. 2016 Apr;39(4):287-94. doi: 10.1007/s40264-015-0365-x. Review.

PMID:
26748508
19.

Genetic counselling in a national referral centre for pulmonary hypertension.

Girerd B, Montani D, Jaïs X, Eyries M, Yaici A, Sztrymf B, Savale L, Parent F, Coulet F, Godinas L, Lau EM, Tamura Y, Sitbon O, Soubrier F, Simonneau G, Humbert M.

Eur Respir J. 2016 Feb;47(2):541-52. doi: 10.1183/13993003.00717-2015. Epub 2015 Dec 23.

PMID:
26699722
20.

Pulmonary arterial hypertension in patients treated with interferon.

Savale L, Chaumais MC, Sitbon O, Humbert M.

Eur Respir J. 2015 Dec;46(6):1851-3. doi: 10.1183/13993003.01376-2015. No abstract available.

PMID:
26621896

Supplemental Content

Loading ...
Support Center